The results are very encouraging news for Amgen and Repatha, which is in a head-to-head marketing battle with Sanofi and Regeneron’s Praluent to be the dominant PCSK9 inhibitor.

Amgen sets single, lower price of $5,850 for Repatha across the US, hoping to improve Medicare access to the cholesterol drug and revitalise sales growth ...

What to Know About Managing Familial Hypercholesterolemia — A multipronged approach is needed for these patients to achieve adequate cholesterol lowering ...

Use our currency converter to find the live exchange rate between PEN and USD. Convert Peruvian Nuevo Sol to United States Dollar ...

Use our currency converter to find the live exchange rate between USD and PEN. Convert United States Dollar to Peruvian Nuevo Sol ...

Lowering cholesterol can reduce a person’s overall risk of heart disease and heart attack. Learn about lifestyle strategies and drugs that may help.